Stay informed with the latest updates for the inheritable blood disorders community.

Peer-Reviewed Journal Summaries
The First National Patient Satisfaction Survey of U.S. HTCs
The First National Patient Satisfaction Survey of U.S. HTCs
NBDF & Community
Access the World's Largest Hemophilia Repository
Access the World's Largest Hemophilia Repository
Industry
Global Dosing Hold in Fitusiran Trials Initiated by Sanofi Genzyme to Investigate New Adverse Events
Global Dosing Hold in Fitusiran Trials Initiated…
COVID-19
Register for COVID-19 Vaccines: What to Expect
Register for COVID-19 Vaccines: What to Expect
NBDF & Community
Highlights from NHF's Virtual Insurance and Reimbursement Conference
Highlights from NHF's Virtual Insurance and Reimbursement Conference
Press Releases
With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies
With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies
NBDF & Community
NHF Announces 2020 Kevin Child Scholarship Winner
NHF Announces 2020 Kevin Child Scholarship Winner
NBDF & Community
Public Health Symposia Now Available on the NHF Website!
Public Health Symposia Now Available on the NHF Website!
Advocacy & Legislative
Americans Believe Government Should Require Copay Assistance Be Applied to Out-of-pocket Costs
Americans Believe Government Should Require Copay…
Advocacy & Legislative
Patient Advocacy Organizations Release Blueprint to Protect Access to Care
Patient Advocacy Organizations Release Blueprint to Protect Access to Care…
Industry
First Patient Dosed in Phase 3 Gene Therapy Trial
First Patient Dosed in Phase 3 Gene Therapy Trial
NBDF & Community
NHF's Red Tie Soiree is a Virtual Success
NHF's Red Tie Soiree is a Virtual Success
COVID-19
Gene Therapy: What's New & What's Next Webinar
Gene Therapy: What's New & What's Next Webinar
Medical
HHS Announces New Coronavirus Funding for Healthcare Providers
HHS Announces New Coronavirus Funding for Healthcare Providers
Medical
Last Chance to Access Accredited Education on Females with Bleeding Disorders
Last Chance to Access Accredited Education on Females with Bleeding…